BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Pharma Research

South Korea Scientists Introduce MUTE Seq For Ultra Sensitive Cancer Mutation Detection In Liquid Biopsy

MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can distinguish single-base mismatches acros...

December 10, 2025 | News

Mango Sciences Partners with ImmunoACT to Expand Access to NexCAR19 CAR-T Therapy in India

Mango Sciences, Inc., the Boston, US, and Bengaluru, IN-based data and AI company, announced a strategic partnership with ImmunoAdoptive Cell Therapy (Immu...

December 08, 2025 | News

Neurimmune And Alexion Expand Global Collaboration To Advance NI009 For Light Chain Amyloidosis

Neurimmune announced that it has expanded on its transthyretin amyloid cardiomyopathy (ATTR-CM) collaboration with Alexion, AstraZeneca Rare Disease ...

December 05, 2025 | News

Hiropharmaconsulting Secures Japan Patent For First AI Enabled Pharmacovigilance Validation Method

HiroPharmaConsulting (R) Co., Ltd. announced that it has received a patent for an innovative Good Pharmacovigilance Practice (GVP) Computerized System Vali...

December 05, 2025 | News

Kelun Biotech And Crescent Biopharma Forge Global Partnership To Advance Next Generation Oncology Therapies

Companies to advance CR-001, a PD-1 x VEGF bispecific antibody, and SKB105, an integrin beta-6-directed antibody-drug conjugate (ADC), in global markets an...

December 05, 2025 | News

NADMED Launches Global Award to Unlock the Secrets of Cellular Redox Metabolism

As scientists seek to understand the molecular basis of energy production, aging, and disease, one area remains especially elusive: cellular redox metaboli...

December 03, 2025 | News

Sanyou Bio Partners With FatiAbGen to Strengthen Korean Market Presence and Expand Global Biopharma Reach

Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. ("Sanyou Bio") and South Korea's FatiAbGen Co., Ltd. jointly announced the signing of a...

November 28, 2025 | News

HKeyBio Expands Its Autoimmune and Allergy R&D Capabilities With HKEY-AIDMD 3.0 Platform Upgrade

The newly upgraded HKEY-AIDMD 3.0 model library features nearly 300 autoimmune and allergy-related disease models. For multiple major indications, HKeyBi...

November 28, 2025 | News

Exyte Completes Full Integration of Pharmaplan To Strengthen European Leadership in Biopharma Engineering

Exyte, a global leader in the design, engineering, and delivery of high-tech facilities, has completed the integration of Pharmaplan, marking the full tran...

November 26, 2025 | News

Mabwell Doses First Patient in Phase One Two Study of Novel CDH17 Targeting ADC 7MW4911 for Advanced Solid Tumours

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the first patient has been dosed...

November 26, 2025 | News

BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia

BioMed X, a leading external innovation hub for pharma, announced the launch of a new collaborative research project with AbbVie, hosted at the BioMed...

November 26, 2025 | News

Hoth Therapeutics Joins NVIDIA Connect Program to Advance AI Driven Drug Discovery

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company focused on developing breakthrough therapeutics announced that it h...

November 21, 2025 | News

Rafa Laboratories Secures Major BARDA Contract to Advance Intramuscular Tranexamic Acid for Trauma Care

Rafa Laboratories, a global leader in Chemical, Biological, Radiological, and Nuclear hazards medical countermeasures and Biodefense, announced it ha...

November 20, 2025 | News

Vaxcellbio’s CSO Outlines How DDS Enabled Nanobodies Could Redefine Global Treatment Pathways

Vaxcellbio is betting on the combined power of nanobodies and advanced drug delivery science to push boundaries across ophthalmology and other chronic dise...

November 20, 2025 | Interaction

Stay Connected